Navigation Links
Arpida Announces Review of Iclaprim NDA by FDA Advisory Committee in November 2008
Date:10/14/2008

Drug User Fee Act (PDUFA) goal date will be 16 January 2009. Arpida submitted a Marketing Authorisation Application for intravenous iclaprim with EMEA in July 2008. EMEA notified that it had accepted the MAA for review in August 2008.

In December 2007, Arpida announced the enrolment of the first patients in a Phase II clinical study with intravenous iclaprim in the treatment of patients with hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP) or healthcare associated pneumonia (HCAP).

In May 2008, Arpida announced the enrolment of the first patients in a Phase II 'intravenous-to-oral' switch trial. Iclaprim could be offered not only as an intravenous therapy for hospital use in acute situations, but also as an oral formulation, allowing early patient discharge followed by outpatient treatment. This switch could be a valuable instrument in reducing healthcare costs and enhancing patient comfort.

Arpida's fourth most advanced antibiotic programme, AR-709, targets upper and lower respiratory tract infections acquired in the community setting. AR-709 exhibited potent activity against a large panel of pneumococcal clinical isolates including those resistant to currently used drugs. Results of "first-in-man" studies with AR-709 were published in March 2007.

An additional antibacterial compound, AR-2474, has demonstrated in vivo proof of concept. AR-2474 has been shown to be effective in eradicating pathogens in preclinical models of skin infection and nasal carriage.

Apart from the antibiotic programmes, Arpida has an innovative antifungal therapy (TLT) which is in Phase III clinical trials in Europe, targeting onychomycosis.

Moreover, the company has several other leads in optimisation and additional discovery programmes derived from its own discovery platform at various research stages.

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assu
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
2. Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
3. Arpida Provides Further Comments on the Pivotal Phase III Trials
4. Arpida Invited to Present Data on Iclaprim at Scientific Conference
5. Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data
6. Facet Solutions Announces Completion of 6 Month Follow-Up in US Pilot Study
7. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
8. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
9. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
10. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
11. Burcon announces GRAS status for Puratein(R) & Supertein(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 The National Necrotizing ... Fernando Davila has been successfully treated for a life ... Dr, Anibal R. Gauto , Medical Director of Inpatient ... Eisenhower Medical Center in Rancho Mirage, California ... pioneered by Dr. John Crew at Seton Hospital ...
(Date:8/20/2014)...   Ventana Medical Systems, Inc.  (Ventana), a ... its VENTANA System for Primary Diagnosis 1 ... for routine pathology, including primary diagnosis with human ... software coupled with either the VENTANA iScan Coreo ... automated digital slide creation, case management and computer ...
(Date:8/20/2014)... , Aug. 20, 2014 ApolloDx™ today announced ... platform during a special event at the company,s office ... on September 5, 2014. The event, which will start ... ApolloDx website, www.apollodx.com .    "We ... said Jared Bauer , Co-Founder and Managing Partner ...
Breaking Medicine Technology:Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3
... Despite a fragile economy, America,s pharmaceutical research and biotechnology companies invested a record $65.3 billion ... than $1.5 billion from 2008, according to analyses by the Pharmaceutical Research and Manufacturers of America ... ... , ...
... , NATICK, Mass. and ATLANTA , ... BSX ) today announced results from an ... trial assessing the impact of diabetes on clinical and ... TAXUS® Express2™ Paclitaxel-Eluting Stent System or the ...
Cached Medicine Technology:R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges 2R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges 3R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges 4R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges 5R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges 6Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 2Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 3Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 4Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 5Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack 6
(Date:8/21/2014)... Recently nominated as the Women’s Radio Network’s ... to be the man he is today. Growing up, KC ... positive look on women, respecting them as professionals and individuals. Through ... thanks to a man who he had the pleasure of working ... KC Armstrong’s name will ring a bell to most of you ...
(Date:8/21/2014)... August 21, 2014 Today, Fecbek.com, a ... its new designs of wedding dresses. And all these ... are designed by excellent designers. , A wedding dress ... bride during a wedding ceremony. Color, style and ceremonial ... and culture of the wedding participants. In order to ...
(Date:8/20/2014)... 21, 2014 On September 7th, 2014 Peoria ... organization connects people living with MS with people who care. ... and are 85% of the way to their goal. This ... begins at 11:30 and the walk starts at 1:00 ... to answer question about chiropractic care and how it helps ...
(Date:8/20/2014)... In less than a week the ... donations to fight muscle related disease. Helping the huge ... and brands through their cause-related marketing heft. With their ... raised nearly $60 million. , But for small self-serve ... franchisees, cause-related marketing remains decidedly local and, although the ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Coolercovers.com, ... Products, announces the availability of select products on ... ordering capabilities aims to increase product availability and ... complete line of canvas covers for air conditioners ... Bryant, Lennox, Rheem, Payne, Armstrong, Amana, Carrier, Trane, ...
Breaking Medicine News(10 mins):Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2Health News:Elegant Wedding Dresses Are for Sale at Fecbek.com 2Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2Health News:On Eve of Big Telethon, Froyo Businesses Participate but Also Go Their Own -- Local Way 2Health News:On Eve of Big Telethon, Froyo Businesses Participate but Also Go Their Own -- Local Way 3Health News:Air Conditioner Covers for Most A/C Units Now Available Online at Coolercovers.com and Amazon.com 2Health News:Air Conditioner Covers for Most A/C Units Now Available Online at Coolercovers.com and Amazon.com 3
... Program Urges Americans to ,Fight Against Heart ... ... U.S. adults are confused about,what heart failure is, cannot recognize common ... manageable condition, according,to a new survey conducted by Harris Interactive(R) on ...
... becomes newest reseller ... wireless microphone, MAYNARD, Mass., Feb. 12 ... enhancing collaboration, today announced,that the Dictaphone Healthcare Solutions ... Wireless Microphone alongside its Dragon(R),NaturallySpeaking(R) Medical speech recognition ...
... Day E-Cards, Find Inspiration in Video Blogs on,DeterminedToQuit.com, ... video blogs documenting their efforts to quit using ... of Health,s new tobacco,cessation Web site, http://www.DeterminedToQuit.com ... married for a little more than a,year and ...
... Campaign to Eliminate Compounded Hormones, WASHINGTON, ... Pharmacists (IACP) today called on the American,Association ... American,Menopause Society (NAMS) to fully disclose their ... patients and practitioners that directly benefits,the pharmaceutical ...
... have underlying speech deficits , , TUESDAY, Feb. 12 ... history of learning disabilities may be more at risk ... to lose language abilities as they age, according to ... primary progressive aphasia, causes language abilities to be slowly ...
... recent announcement by,the United States Food and Drug Administration ... (botulinum toxin type A), customers are,looking for alternatives to ... approval in 2002 for the temporary treatment of,moderate to ... to 65 years,of age. In its recent communication, the ...
Cached Medicine News:Health News:New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 2Health News:New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 3Health News:New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 4Health News:New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 5Health News:New Survey Suggests Confusion, Lack of Awareness About Heart Failure Could Be Preventing Critical Early Detection and Treatment 6Health News:Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance 2Health News:Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance 3Health News:American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals 2Health News:Learning Disabilities May Presage Later Language Problems 2Health News:Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles 2
... pessary is designed for third ... well as a cystocele and ... available both with and without ... silicone tie to aid in ...
The Incontinence Dish is used to relieve stress incontinence and minor degrees of prolapse. The Incontinence Dish comes with and without support. It is available in eight different sizes....
The Shaatz pessary, available in nine sizes, is used for a first to second degree prolapse and an accompanying cystocele....
... are among the smallest and ... with advanced reporting software that ... information. Extensive testing by independent ... accuracy, making it widely recognized ...
Medicine Products: